Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
No hGH Receptor Binding or IGF-1 Stimulation AOD9604 did not induce hyperglycaemia or reduce insulin secretion in sharp contrast to chronic intact hGH treatment and confirmed that the concept of hGH behaving as a pro-hormone is valid, with fragments capable of acting via mechanisms novel to traditional GH receptor-stimulated pathways
Compared to other peptides for fat loss The peptide landscape for fat loss includes several options beyond GLP-1 agonists
Stefano Sinicropi , Founder of HyperCharge Health and HyperCharge Wellness Clinics Disclaimer: This blog is for informational purposes only and is not intended as medical advice
No pharmacokinetic or pharmacodynamic interaction studies exist for the combination
AOD9604 has been studied in preclinical and early clinical settings, and it received GRAS (Generally Recognized as Safe) designation from the US FDA for use as a food ingredient
